Internal Medicine, Hematology & Oncology · Oklahoma City, OK
NPI
1215988803
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
4301 S Western Ave
Oklahoma City, OK, 73109
Phone (405) 631-0919
Groups this clinician bills Medicare through
Medicare paid, 2024
$100K
1,681 services
Medicare patients, 2024
473
Average age 75
Drug cost, 2024
$4.5M
2,137 prescriptions
Company payments, 2025
$445
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Bashar S Alasad was code 99214 (office e&m - established), 649 times for 219 patients. In total Bashar S Alasad billed 1,681 services in 13 codes, and Medicare paid $100K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-06-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 649 | 219 | $64.48 | $42K |
| 99213 Office E&M - Established | Facility | 507 | 294 | $41.75 | $21K |
| 99232 Hospital E&M - Subsequent | Facility | 329 | 76 | $58.21 | $19K |
| 99222 Hospital E&M - Initial | Facility | 54 | 47 | $96.94 | $5,235 |
| 99204 Office E&M - New | Facility | 49 | 49 | $84.66 | $4,148 |
| 99215 Office E&M - Established | Facility | 36 | 21 | $94.26 | $3,393 |
| 38222 Other Organ Systems | Facility | 16 | 15 | $46.07 | $737 |
| 99205 Office E&M - New | Facility | 14 | 14 | $134.53 | $1,883 |
| 99223 Hospital E&M - Initial | Facility | 14 | 14 | $128.35 | $1,797 |
By year: 2022 $105K for 1,780 services; 2023 $111K for 1,777 services; 2024 $100K for 1,681 services.
Medicare prescription drug claims, 2024
In 2024, the drug Bashar S Alasad prescribed most often to Medicare patients was Levothyroxine Sodium, with 151 prescriptions and refills. In total Bashar S Alasad wrote 2,137 Medicare prescriptions that cost $4.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 151 | 309 | 38 | $1,228 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 147 | 147 | 35 | $2,796 |
| Anastrozole Generic | 145 | 391 | 41 | $2,852 |
| Prednisone Generic | 92 | 94 | 37 | $360 |
| Prochlorperazine Maleate Generic | 84 | 84 | 39 | $1,141 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 83 | 83 | 17 | $2,151 |
| Jakafi Ruxolitinib Phosphate | 70 | 70 | Under 11 | $1.2M |
| Eliquis Apixaban | 60 | 98 | 14 | $52K |
| Alendronate Sodium Generic | 59 | 123 | 14 | $547 |
| Abiraterone Acetate Generic | 54 | 54 | Under 11 | $152K |
| Potassium Chloride Generic | 46 | 67 | 25 | $234 |
| Lidocaine-Prilocaine Lidocaine/Prilocaine | 45 | 45 | 37 | $574 |
| Gabapentin Generic | 43 | 55 | Under 11 | $484 |
| Revlimid Lenalidomide | 43 | 43 | Under 11 | $688K |
| Tamoxifen Citrate Generic | 40 | 97 | 12 | $1,512 |
Brand drugs: - claims; generic drugs: 1,646 claims; opioid claims: 311.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Bashar S Alasad $445 ($445 in general payments such as food, travel and fees) from 16 companies. The largest payer was Intuitive Surgical, Inc. with $73.96.
| Company | Payments | Amount |
|---|---|---|
| Intuitive Surgical, Inc. ISRG | 1 | $73.96 |
| Sobi, Inc SOBI.ST | 2 | $54.36 |
| E.R. Squibb & Sons, L.L.C. BMY | 3 | $49.97 |
| Daiichi Sankyo Inc. 4568.T | 2 | $48.69 |
| Abbvie Inc. ABBV | 1 | $33.18 |
| Array Biopharma Inc PFE | 1 | $26.11 |
| Pfizer Inc. PFE | 1 | $25.66 |
| Novartis Pharmaceuticals Corporation NVS | 1 | $23.2 |
| Aveo Pharmaceuticals, Inc. | 1 | $20 |
| Exelixis Inc. EXEL | 1 | $19.39 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.